Prestige Consumer Healthcare (PBH) Net Income towards Common Stockholders (2010 - 2025)

Prestige Consumer Healthcare's Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at $46.7 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders fell 23.49% year-over-year to $46.7 million; the TTM figure through Dec 2025 stood at $186.5 million (down 12.82% YoY), while the FY2025 annual figure was $214.6 million, up 2.52% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at $46.7 million, up from $42.2 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $61.0 million in Q4 2024, with the low at -$240.6 million in Q1 2023.
• The 5-year median for Net Income towards Common Stockholders is $50.6 million (2021), against an average of $35.9 million.
• The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders tumbled 561.84% in 2023, then surged 120.56% in 2024.
• Prestige Consumer Healthcare's Net Income towards Common Stockholders stood at $50.2 million in 2021, then grew by 3.46% to $52.0 million in 2022, then climbed by 2.11% to $53.0 million in 2023, then climbed by 15.05% to $61.0 million in 2024, then slipped by 23.49% to $46.7 million in 2025.
• Business Quant data shows PBH's Net Income towards Common Stockholders at $46.7 million in Q4 2025, $42.2 million in Q3 2025, and $47.5 million in Q2 2025.